Philips shares climb after finalizing pact with U.S. over device sales
By Steve Goldstein
Philips reiterated its financial outlook on Wednesday after finalizing a consent degree with the U.S. Department of Justice and Food and Drug Administration that will prevent it from selling new respiratory care devices in the U.S. but will allow for exports.
The agreement focuses on its U.S. respironics business that is headquartered in Pittsburgh, after it stopped selling Continuous Positive Airway Pressure or Bilevel Positive Airway Pressure sleep therapy devices and other respiratory care devices in 2021 following a recall over the risk that foam would break down and be swallowed.
Philips is still allowed to service devices and sell accessories.
Philips shares (NL:PHIA) (PHG) jumped 4% in early Amsterdam trade. The stock is down 6% this year.
The Food and Drug Administration said the consent decree requires a recall remediation plan providing for either new or remediated devices or refunds. The FDA said Philips will have to receive written notice they're in compliance on current good manufacturing practice, reporting corrections and removals and medical device reporting.
Philips said it still expects "costs of around 100 basis points" this year for remediation activities and profit disgorgement payments, as it reiterated its guidance that calls for mid single digit sales growth and low teens margins excluding those costs.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-10-24 0330ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software